48th week of 2019 patent applcation highlights part 23 |
Patent application number | Title | Published |
20190359621 | BICYCLIC UREA COMPOUNDS AND THEIR USE AS SOLVENT | 2019-11-28 |
20190359622 | ANALOGS OF VINCAMINE AND USES THEREOF | 2019-11-28 |
20190359623 | COMPOUNDS | 2019-11-28 |
20190359624 | SORBITOL BASED GELATORS AND METHOD THEREOF | 2019-11-28 |
20190359625 | A SIMPLIFIED PROCEDURE FOR THE PREPARATION OF DARUNAVIR | 2019-11-28 |
20190359626 | TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS AGAINST HIV/AIDS | 2019-11-28 |
20190359627 | OXABICYCLOHEPTANE PRODRUGS | 2019-11-28 |
20190359628 | Thienopyrazine Carboxamides as Ubiquitin-Specific Protease Inhibitors | 2019-11-28 |
20190359629 | THIENOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | 2019-11-28 |
20190359630 | TRICYCLIC COMPOUNDS HAVING ANTIMITOTIC AND/OR ANTITUMOR ACTIVITY AND METHODS OF USE THEREOF | 2019-11-28 |
20190359631 | THERAPEUTIC AGENT FOR MOTOR DISORDERS | 2019-11-28 |
20190359632 | METHOD FOR THE MANUFACTURING OF 2-(3-(ALKYL AND ALKENYL)MORPHOLINO)-ETHAN-1-OLS | 2019-11-28 |
20190359633 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | 2019-11-28 |
20190359634 | ASK1 INHIBITING AGENTS | 2019-11-28 |
20190359635 | ISOTHIAZOLOPYRIMIDINONES, PYRAZOLOPYRIMIDINONES, AND PYRROLOPYRIMIDINONES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS | 2019-11-28 |
20190359636 | PROTEASOME INHIBITORS | 2019-11-28 |
20190359637 | Bisaminoalkoxysilane Compounds And Methods For Using Same To Deposit Silicon-Containing Films | 2019-11-28 |
20190359638 | Nucleotide Analogs | 2019-11-28 |
20190359639 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | 2019-11-28 |
20190359640 | Metal Complexes Containing Allyl Ligands | 2019-11-28 |
20190359641 | CHIRAL SOLVATING AGENTS | 2019-11-28 |
20190359642 | IONIC SOLID | 2019-11-28 |
20190359643 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | 2019-11-28 |
20190359644 | PROCESSES AND INTERMEDIATES FOR PREPARING ANTI-HIV AGENTS | 2019-11-28 |
20190359645 | 2'3'-CYCLIC DINUCLEOTIDES COMPRISING CARBOCYCLIC NUCLEOTIDE | 2019-11-28 |
20190359646 | OXYSTEROLS AND METHODS OF USE THEREOF | 2019-11-28 |
20190359647 | C-3 AND C-17 MODIFIED TRITERPENOIDS AS HIV-1 INHIBITORS | 2019-11-28 |
20190359648 | NOVEL SALTS AND POLYMORPHS OF SCY-078 | 2019-11-28 |
20190359649 | SEPARATING AGENT FOR HUMAN INSULIN PURIFICATION AND HUMAN INSULIN PURIFICATION METHOD | 2019-11-28 |
20190359650 | METHODS FOR EXTRACTING KERATIN PROTEINS | 2019-11-28 |
20190359651 | CENTRAL NERVOUS SYSTEM HOMING PEPTIDES AND USES THEREOF | 2019-11-28 |
20190359652 | PEPTIDE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, OR PRODRUG THEREOF | 2019-11-28 |
20190359653 | SELECTIVE PEPTIDE INHIBITORS OF FRIZZLED | 2019-11-28 |
20190359654 | CYCLIC PEPTIDE FOR TREATING CANCER | 2019-11-28 |
20190359655 | FcRn-Targeted Mucosal Vaccination Against Influenza Infections | 2019-11-28 |
20190359656 | Alphavirus NSP Mutants as Vaccines | 2019-11-28 |
20190359657 | MULTIVALENT CD20-BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS AND ENRICHED COMPOSITIONS THEREOF | 2019-11-28 |
20190359658 | TREATMENT OF DIABETES, TOLL-LIKE RECEPTOR 4 MODULATORS AND METHODS FOR USING THE SAME | 2019-11-28 |
20190359659 | COMPOSITIONS AND METHODS FOR ENHANCED PRODUCTION OF ENDURACIDIN IN A GENETICALLY ENGINEERED STRAIN OF STREPTOMYCES FUNGICIDICUS | 2019-11-28 |
20190359660 | Peptides And Methods For Detecting Peanut Allergies | 2019-11-28 |
20190359661 | METHOD AND DEVICE FOR PAIN MODULATION BY OPTICAL ACTIVATION OF NEURONS AND OTHER CELLS | 2019-11-28 |
20190359662 | SPIDER VENOM PEPTIDES AND METHODS OF USE FOR MODULATING SODIUM CHANNELS | 2019-11-28 |
20190359663 | LIVER-TYPE FATTY ACID-BINDING PROTEIN STANDARD, METHOD FOR EVALUATING STANDARD, METHOD FOR REGULATING VARIATION RANGE OF MEASURED VALUE CAUSED BY LIVER-TYPE FATTY ACID-BINDING PROTEIN IN MEASUREMENT USING STANDARD, LIVER-TYPE FATTY ACID-BINDING PROTEIN, DNA ENCODING PROTEIN, CELL TRANSFORMED BY DNA, METHOD OF PRODUCING PROTEIN, METHOD OF DRAWING CALIBRATION CURVE FOR LIVER-TYPE FATTY ACID-BINDING PROTEIN, AND METHOD OF QUANTIFYING PROTEIN | 2019-11-28 |
20190359664 | RSPONDINS AS MODULATORS OF ANGIOGENESIS AND VASCULOGENESIS | 2019-11-28 |
20190359665 | METHOD FOR THE AFFINITY PURIFICATION OF RECOMBINANT PROTEINS BASED ON THE LECTIN ACTIVITY OF THE CRD OF A GALECTIN | 2019-11-28 |
20190359666 | RECOMBINANT PROTEINS AND USES THEREOF | 2019-11-28 |
20190359667 | ENGINEERED TGF-BETA MONOMERS AND THEIR USE FOR INHIBITING TGF-BETA SIGNALING | 2019-11-28 |
20190359668 | THERAPEUTIC USE OF BONE MORPHOGENETIC PROTEINS | 2019-11-28 |
20190359669 | CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF | 2019-11-28 |
20190359670 | AGENT FOR PROMOTING ANGIOGENESIS AND METHODS AND USES THEREOF | 2019-11-28 |
20190359671 | NEW COMPOSITIONS, METHODS AND USES | 2019-11-28 |
20190359672 | INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE | 2019-11-28 |
20190359673 | POLYPEPTIDE DERIVATIVES FROM GRASS CARP INTERFERON AND APPLICATION THEREOF | 2019-11-28 |
20190359674 | PROTEOLICALLY RESISTANT CYCLOTIDES WITH ANGIOTENSIN 1-7 LIKE ACTIVITY | 2019-11-28 |
20190359675 | METHOD FOR PREPARING LIRAGLUTIDE INTERMEDIATE POLYPEPTIDE | 2019-11-28 |
20190359676 | HEPARIN-BINDING DOMAIN OF IGFBP-2 IN THE TREATMENT OF METABOLIC DISORDERS | 2019-11-28 |
20190359677 | NOVEL T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME FOR THE TREATMENT OF CANCER AND INFECTIOUS DISEASES | 2019-11-28 |
20190359678 | CHIMERIC T CELL ANTIGEN RECEPTORS AND METHODS OF USE THEREOF | 2019-11-28 |
20190359679 | DIAGNOSTIC, PROGNOSTIC, THERAPEUTIC AND SCREENING PROTOCOLS | 2019-11-28 |
20190359680 | CS1 SPECIFIC MULTI-CHAIN CHIMERIC ANTIGEN RECEPTOR | 2019-11-28 |
20190359681 | NOVEL MINOR HISTOCOMPATIBILITY ANTIGENS AND USES THEREOF | 2019-11-28 |
20190359682 | INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR | 2019-11-28 |
20190359683 | Ciliary Neurotrophic Factor Receptor Ligand-Binding Agents and Methods of Using the Same | 2019-11-28 |
20190359684 | TIM-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND TIM-3 ANTIGEN BINDING DOMAINS | 2019-11-28 |
20190359685 | Chimeric Antigen Receptors | 2019-11-28 |
20190359686 | FLUORESCENT FUSION POLYPEPTIDE CAPABLE OF DETECTING PHOSPHORYLATION OF CELLULAR MEMBRANE RECEPTORS BY GRKS (G-PROTEIN RECEPTOR KINASES) AND/OR RECEPTOR TYROSINE KINASES (RTKS) | 2019-11-28 |
20190359687 | RED BLOOD CELL TARGETED FACTOR VIII AND METHOD OF USING THE SAME | 2019-11-28 |
20190359688 | Polypeptides Targeting HIV Fusion | 2019-11-28 |
20190359689 | MODIFIED COLLAGEN | 2019-11-28 |
20190359690 | THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS | 2019-11-28 |
20190359691 | METHOD FOR PROMOTING DIVERSIFICATION OF ANTIBODY VARIABLE REGION | 2019-11-28 |
20190359692 | METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA | 2019-11-28 |
20190359693 | BINDING MOLECULES DIRECTED AGAINST INFLUENZA HEMAGGLUTININ AND USES THEREOF | 2019-11-28 |
20190359694 | SEROLOGICAL ASSAY FOR ZIKA VIRUS INFECTION | 2019-11-28 |
20190359695 | RECOMBINANT EXPRESSION SYSTEMS AND PRODUCTS | 2019-11-28 |
20190359696 | CONNEXIN (CX) 43 HEMICHANNEL-BINDING ANTIBODIES AND USES THEREOF | 2019-11-28 |
20190359697 | CHIMERIC ANTIGEN RECEPTOR EFFECTOR CELL SWITCHES WITH HUMANIZED TARGETING MOIETIES AND/OR OPTIMIZED CHIMERIC ANTIGEN RECEPTOR INTERACTING DOMAINS AND USES THEREOF | 2019-11-28 |
20190359698 | ANTI-GPC3 ANTIBODY | 2019-11-28 |
20190359699 | ANTI-FACTOR D ANTIBODIES AND USES THEREOF | 2019-11-28 |
20190359700 | Anti-CcL8 Antibodies and Uses Thereof | 2019-11-28 |
20190359701 | METHODS OF TREATING DISEASES | 2019-11-28 |
20190359702 | IL-31 DOG PRURITUS MODEL | 2019-11-28 |
20190359703 | ANTI-IL4-IL13 BISPECIFIC ANTIBODIES | 2019-11-28 |
20190359704 | TARGET TISSUE-SPECIFIC ANTIGEN-BINDING MOLECULE | 2019-11-28 |
20190359705 | Interferon Alpha and Omega Antibody Antagonists | 2019-11-28 |
20190359706 | LINGO-2 ANTAGONISTS FOR TREATMENT OF CONDITIONS INVOLVING MOTOR NEURONS | 2019-11-28 |
20190359707 | Anti-Sirpa Antibodies and Methods of Use Thereof | 2019-11-28 |
20190359708 | COMPOSITIONS COMPRISING SOLUBLE CD84 OR ANTI-CD84 ANTIBODIES AND METHODS FOR DIAGNOSING AND TREATING B-CLL | 2019-11-28 |
20190359709 | PHARMACEUTICAL PREPARATION STABLY COMPRISING CD147 MONOCLONAL ANTIBODY | 2019-11-28 |
20190359710 | A CD33-, CD16- AND CD123-SPECIFIC SINGLE CHAIN TRIPLEBODY | 2019-11-28 |
20190359711 | MONOSPECIFIC AND MULTISPECIFC ANTI-TMEFF2 ANTIBODIES AND THEIR USES | 2019-11-28 |
20190359712 | ANTI-CD3 ANTIBODY AND MOLECULES COMPRISING THE ANTIBODY | 2019-11-28 |
20190359713 | MOLECULES WITH SPECIFICITY FOR CD45 AND CD79 | 2019-11-28 |
20190359714 | Activatable Anti-CTLA-4 Antibodies and Uses Thereof | 2019-11-28 |
20190359715 | ANTI-PD-L1 ANTIBODY TREATMENT OF BLADDER CANCER | 2019-11-28 |
20190359716 | MULTI-SPECIFIC BINDING PROTEINS FOR ACTIVATION OF NATURAL KILLER CELLS AND THERAPEUTIC USES THEREOF TO TREAT CANCER | 2019-11-28 |
20190359717 | ANTI-cMET ANTIBODY | 2019-11-28 |
20190359718 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING INFLAMMATION | 2019-11-28 |
20190359719 | Antigen Binding Proteins That Bind C-Met | 2019-11-28 |
20190359720 | ST2 ANTIGEN BINDING PROTEINS | 2019-11-28 |